IL6 and metastatic melanoma: As was observed with the MCA-OVA, OT-II cells primed with peptide-pulsed DCs were ineffective for metastatic melanoma in aged IL-6+/+ mice compared with those in young IL-6+/+ or IL-6−/− mice (Fig. 2a).